Ascelia Pharma AB (OSTO:ACE) Effective Interest Rate on Debt %: 122.48% (As of Mar. 2026)


OSTO:ACE Ascelia Pharma AB OSTO:ACE
28 GF Score
Price kr0.66
! 1 Warning Sign
View Full Analysis

What is Ascelia Pharma AB Effective Interest Rate on Debt %?

Ascelia Pharma AB OSTO:ACE -1.48% 28 Effective Interest Rate on Debt % is 122.48% as of Mar. 2026. GuruFocus rates OSTO:ACE with a GF Score™ of 28/100. The stock has 1 warning sign investors should review.

Effective Interest Rate on Debt % is the usage rate that a borrower actually pays on a debt. It is calculated as the positive value of Interest Expense divided by its average total debt. Total debt equals to Long-Term Debt & Capital Lease Obligation plus Short-Term Debt & Capital Lease Obligation. Ascelia Pharma AB's annualized positive value of Interest Expense for the quarter that ended in Mar. 2026 was kr1.02 Mil. Ascelia Pharma AB's average total debt for the quarter that ended in Mar. 2026 was kr0.83 Mil. Therefore, Ascelia Pharma AB's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2026 was 122.48%.


Ascelia Pharma AB  (OSTO:ACE) Effective Interest Rate on Debt % Explanation

Effective Interest Rate on Debt % measures the usage rate that a borrower actually pays on a debt.


Ascelia Pharma AB Effective Interest Rate on Debt % Related Terms


Ascelia Pharma AB Effective Interest Rate on Debt % Historical Data

* Premium members only.

The historical data trend for Ascelia Pharma AB's Effective Interest Rate on Debt % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ascelia Pharma AB Effective Interest Rate on Debt % Chart

Ascelia Pharma AB Annual Data
Trend Jun17 Jun18 Jun19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Effective Interest Rate on Debt %
Get a 7-Day Free Trial Premium Member Only 4.49 4.49 0.00 28.01 12.89

Ascelia Pharma AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Effective Interest Rate on Debt % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 34.04 45.79 76.57 126.43 122.48

OSTO:ACE vs VRTX, REGN, ALNY: Effective Interest Rate on Debt % Comparison

For the Biotechnology subindustry, Ascelia Pharma AB's Effective Interest Rate on Debt %, along with its competitors' market caps and Effective Interest Rate on Debt % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ascelia Pharma AB Effective Interest Rate on Debt % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Ascelia Pharma AB's Effective Interest Rate on Debt % distribution charts can be found below:

* The bar in red indicates where Ascelia Pharma AB's Effective Interest Rate on Debt % falls into.


OSTO:ACE
28GF Score
Ascelia Pharma AB OSTO:ACE
Effective Interest Rate on Debt % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ascelia Pharma AB Effective Interest Rate on Debt % Calculation

Ascelia Pharma AB's annualized Effective Interest Rate on Debt % for the fiscal year that ended in Dec. 2025 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (A: Dec. 2024 )+Total Debt  (A: Dec. 2025 ))/ count )
=-1  *  -1.699/( (25.397+0.97)/ 2 )
=-1  *  -1.699/13.1835
=12.89 %

where

Total Debt  (A: Dec. 2024 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0 + 25.397
=25.397

Total Debt  (A: Dec. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.072 + 0.898
=0.97

Ascelia Pharma AB's annualized Effective Interest Rate on Debt % for the quarter that ended in Mar. 2026 is calculated as

Effective Interest Rate on Debt %
=-1  *  Interest Expense/( (Total Debt  (Q: Dec. 2025 )+Total Debt  (Q: Mar. 2026 ))/ count )
=-1  *  -1.016/( (0.97+0.689)/ 2 )
=-1  *  -1.016/0.8295
=122.48 %

where

Total Debt  (Q: Dec. 2025 )
=Long-Term Debt & Capital Lease Obligation + Short-Term Debt & Capital Lease Obligation
=0.072 + 0.898
=0.97

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Effective Interest Rate on Debt %, the Interest Expense of the last fiscal year and the average total debt over the fiscal year are used. In calculating the quarterly data, the Interest Expense data used here is four times the quarterly (Mar. 2026) interest expense data. Effective Interest Rate on Debt % is displayed in the 30-year financial page.

What does a Effective Interest Rate on Debt % of 122.48% mean?
Ascelia Pharma AB (OSTO:ACE) has a Effective Interest Rate on Debt % of 122.48% as of Mar. 2026. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Ascelia Pharma AB and its competitors.
Is Ascelia Pharma AB's Effective Interest Rate on Debt % too high?
Ascelia Pharma AB's current Effective Interest Rate on Debt % is 122.48%. Overall, Ascelia Pharma AB has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Ascelia Pharma AB's Effective Interest Rate on Debt % compare to VRTX and REGN?
Ascelia Pharma AB's Effective Interest Rate on Debt % of 122.48% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Effective Interest Rate on Debt % for a Biotechnology company?
A good Effective Interest Rate on Debt % depends on the Biotechnology industry context. However, Effective Interest Rate on Debt % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Effective Interest Rate on Debt % mean?
A high Effective Interest Rate on Debt % can signal that a stock is expensive relative to its fundamentals. Effective interest rate on debt is the rate a company actually pays on its debt. View historical data on Ascelia Pharma AB and its competitors. Ascelia Pharma AB's current Effective Interest Rate on Debt % is 122.48%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ascelia Pharma AB stock overvalued right now?
Ascelia Pharma AB (OSTO:ACE) has a current Effective Interest Rate on Debt % of 122.48%. The current Effective Interest Rate on Debt % is 122.48%. Ascelia Pharma AB's overall GF Score™ is 28/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Effective Interest Rate on Debt % calculated?
Effective Interest Rate on Debt % is calculated from a company's financial statements. For Ascelia Pharma AB (OSTO:ACE), the current Effective Interest Rate on Debt % is 122.48% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Ascelia Pharma AB Business Description

Other Exchanges ACEs:UK
Address Hyllie Boulevard 34, Malmo, SWE, 215 32
Ascelia Pharma AB is a biotech company focused on orphan oncology treatments. The company develops and commercializes novel drugs that address unmet medical needs and have a clear development and market pathway. It has two drug candidates, Orviglance and Oncoral, in development. Orviglance (manganese chloride tetrahydrate) is an oral contrast agent for MR imaging developed to improve the detection and visualization of focal liver lesions (including liver metastases and primary tumors) in patients with impaired kidney function, and Oncoral is a novel oral irinotecan tablet in development.
28GF Score

Get the complete analysis for OSTO:ACE

Effective Interest Rate on Debt % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr0.66
Price